Dana Farber and 454 life sciences announce breakthrough in DNA sequencing

454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation, in collaboration with scientists at Dana Farber Cancer Center and Broad Institute, today reported a new method for the detection of cancer gene mutations present at extremely low levels.

It is heartwarming to see that the scientific community is working ever closer to curing cancer. I just wish they could have saved my aunt from dying of breast cancer. :/

read more | digg story




It seems you're using an unsafe, out-of-date browser. Click here to upgrade to Firefox for free. X